P-61 Comparison of general toxicological parameters between Crj : CD (SD) IGS and Slc : SD rats(Proceedings of the 27th Annual Meeting)
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 2000-10-31
著者
-
Iidaka Takeshi
ファイザー 中央研究所
-
Iidaka Takeshi
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究統括部
-
Iidaka Takeshi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究
-
Kurata Masaaki
ファイザー製薬中央研究所 安全性研究統括部
-
TSUJIMURA Yumiko
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
KURATA Masaaki
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
IIDAKA Takeshi
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
TAKAHASHI Mamoru
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
SHIMOYA Machiko
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
KATO Mariko
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
FURUTA Chikako
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
SHIRAI Norimitsu
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
SATO Yasushi
Pfizer Pharmaceutical Inc., Drug Safety Evaluation
-
Shirai Norimitsu
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Furuta Chikako
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Shimoya Machiko
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Tsujimura Yumiko
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Kato Mariko
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Takahashi Mamoru
Pfizer Pharmaceutical Inc. Drug Safety Evaluation
-
Sato Yasushi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
関連論文
- P6-38 Relationship between hepatic enzyme induction and carcinogenicity in the p53 deficient mice treated with aminophenylnorharman(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- CELLULAR SIZE OF BONE MARROW CELLS FROM RATS AND BEAGLE DOGS
- PROLONGATION OF PT AND APTT UNDER EXCESSIVE ANTICOAGULANT IN PLASMA FROM RATS AND DOGS
- 3B-04 Effect of Blood Collection Imitating Toxicokinetic Study on Rat Hematological Parameters
- 3B-02 Significance of Cellular Size Mcasurement in Differentiation of Bone Marrow Cells.
- EFFECT OF BLOOD COLLECTION IMITATING TOXICOKINETIC STUDY ON RAT HEMATOLOGICAL PARAMETERS
- Markers for detecting myocardial damage in rats : From a view of clinical pathology(Blood, Biomarker, Proceedings of the 32nd Annual Meeting)
- Erythroderma and Epidermal Necrosis Induced by a Type of Proton Pump Inhibitor in Beagle Dogs
- P-61 Comparison of general toxicological parameters between Crj : CD (SD) IGS and Slc : SD rats(Proceedings of the 27th Annual Meeting)
- SIMULTANEOUS MEASUREMENT OF NUCLEATED CELL COUNTS AND CELLULAR DIFFERENTIALS IN RAT BONE MARROW EXAMINATION USING FLOW CYTOMETER
- MECHANISM FOR SHORTENING PT AND APTT IN DOGS AND RATS : EFFECT OF FIBRINOGEN ON PT AND APTT
- Measurements for rat and canine D-dimer in plasma using human clinical latex agglutination reagents (BLOOD SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Mechanism for shortened PT and APTT in dogs and rats-Effect of fibrinogen on PT and APTT- (BLOOD SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Battery of Tests for Profiling Abnormalities of Vitamin K-Dependent Coagulation Factors in Drug-Toxicity Studies in Rats
- P8-42 Technical examination for repeated blood collection and hematological tests in mice(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P8-41 Simple methods for evaluating abnormality in vitamin K-dependent coagulation factors in rats(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Correlation among Clinicopathological Parameters of Myocardial Damage in Rats Treated with Isoproterenol